November 15, 2017
It was our great pleasure to take part in the 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting, held on November 8–12 in National Harbor, USA. Indivumed, in collaboration with OracleBio, presented a poster showcasing dual immunohistochemistry (IHC) and digital histopathology as one example of the powerful techniques we use to study tumor-infiltrating immune cells. We demonstrated that chromogenic dual IHC and digital quantification of CD3- and LAG-3-positive T cells in clinical samples serves as a useful tool for specific evaluation of immune cell relationships in the tumor microenvironment of NSCLC tissue.
Enter your details here to download the research study poster presentation.